Advances in Medication and Treatment for Sickle Cell Disease
- Dwayne Golden

- Sep 19
- 7 min read

For far too long, people living with sickle cell disease have had to wait while the world around them moved forward in medicine. Other diseases received headlines, funding, and new treatments at a fast pace. Sickle cell patients, many of whom are from communities that face higher rates of poverty and health disparities, continued to suffer in silence. That silence is now breaking.
Recent years have brought a wave of progress. New medications have been approved. Research teams are working harder than ever before. Scientists, doctors, and community advocates are speaking up. There is a stronger push to create real treatment options for a disease that affects over 100,000 Americans. These advances are giving hope, but they also bring new responsibilities. Patients and families must stay informed. They need to know what works today, what is being tested for tomorrow, and how to ask the right questions along the way.
This September, as we honor National Sickle Cell Awareness Month, we also highlight the dedication of organizations like the South Central PA Sickle Cell Council (SCPASCC). These groups are not just talking about awareness. They are working each day to provide answers, resources, and support where it is needed most.
The Changing Landscape of Sickle Cell Care
Sickle cell disease is more than just a condition that causes pain. It affects nearly every part of the body. When red blood cells form the wrong shape, they block blood flow. This can lead to severe pain, damage to organs, infections, and a shorter life expectancy. For years, treatment options were limited to managing pain and hoping to prevent complications.
That old model is finally changing. Researchers now understand more about how sickle cell works at the cellular level. This deeper understanding has opened the door to targeted treatments that aim to reduce the number of painful episodes, improve oxygen flow, and protect long-term health.
This change has not come easy. It took years of work from doctors, scientists, and advocates to move sickle cell from the shadows into the light. More clinical trials are available. The Food and Drug Administration (FDA) has approved new medications. These efforts show progress. Still, this is only the beginning of what needs to be done. Patients deserve to know what is available to them now and what may be coming next.
What Is Available Right Now
One of the most widely used medications for sickle cell is hydroxyurea. This drug has been around for many years and helps the body produce a form of hemoglobin that reduces the number of sickled cells. Many patients who take hydroxyurea experience fewer pain crises and hospital visits. Doctors may recommend it for children as young as nine months old. It is affordable and widely available, but it requires regular monitoring through blood tests.
Another treatment is L-glutamine, sold under the brand name Endari. It is an amino acid that helps reduce stress on red blood cells. People who take it often report fewer pain episodes. This medication is taken by mouth and is approved for patients five years and older. While it does not stop sickle cell itself, it helps the body function better under the pressure of the disease.
A more recent advancement is crizanlizumab, also known as Adakveo. This is a monthly infusion that works by blocking a protein involved in inflammation. By doing this, it lowers the chance of cells sticking to blood vessels and causing pain. Adakveo is approved for patients age sixteen and older. Many people who receive this treatment report fewer crises and improved quality of life. It is given through an IV at a healthcare center.
Each of these medications brings something different to the table. Not every patient will respond the same way. That is why doctors often look at age, health history, and how often pain crises occur before recommending a specific treatment. Patients and families should never feel afraid to ask questions or get a second opinion when deciding on a treatment plan.
What Is in the Pipeline
The world of medical research is moving fast. Some of the most promising developments in sickle cell care are still in clinical trials, but they hold the potential to change how the disease is treated for future generations.
One of the biggest areas of focus is gene therapy. Scientists are exploring ways to change or repair the faulty gene that causes sickle cell. The idea is simple in theory but complex in practice. If the faulty gene can be fixed, the body could start making healthy red blood cells. This would mean fewer crises, less organ damage, and a better overall life expectancy.
Exagamglogene autotemcel, known as exa-cel, is one of the gene therapies showing promise. It has gone through advanced trials and has gained attention for producing strong results. Some patients treated with exa-cel have gone for months or even years without a pain crisis. The treatment involves removing a patient’s bone marrow cells, editing them in a lab, and then putting them back in the body. It is a long process and not without risks, but the results are giving families real hope.
Other research includes drugs that affect how red blood cells interact with blood vessels. Some focus on reducing the stickiness that causes blockages. Others aim to raise fetal hemoglobin levels, which naturally protect against sickling.
While none of these new treatments are widely available yet, many are in the final stages of testing. Patients interested in taking part in a clinical trial should talk with their doctor and visit reliable sources like clinicaltrials.gov. Not every trial is right for every person, but many are safe, well-monitored, and designed to give participants quality care while contributing to science.
What to Ask Your Doctor About New Treatments

When it comes to making decisions about sickle cell treatment, communication with your doctor is critical. Medical teams have access to the latest research and guidelines, but it is up to patients and caregivers to ask clear questions.
Start by asking what treatment options are available based on your age, health condition, and insurance. If you are already on medication, ask whether anything newer might offer better results. Be open about how often pain occurs and how it affects daily life. This information helps your doctor make a more informed decision.
Ask about side effects. Every medication comes with risks, and it is important to understand what to expect. Ask how often you will need blood tests or follow-up appointments. If you hear about a new treatment in the news or online, bring it up during your visit. Good doctors respect a patient’s desire to learn more.
You should also ask whether any clinical trials are available nearby. Many hospitals are working with research teams and can help you find programs that match your needs. If you feel unsure, it is perfectly fine to get a second opinion.
Knowledge is power, especially when dealing with a disease that requires long-term care. The more you ask, the better equipped you will be to make choices that improve your health and peace of mind.
The Power of September

September is National Sickle Cell Awareness Month. This is more than a time for social media posts and red ribbons. It is a moment for the country to listen and learn about a disease that deserves more attention.
Organizations like SCPASCC are leading the charge in South Central Pennsylvania. They host educational events, provide patient support, and meet with schools, churches, and hospitals to spread awareness. Their team works year-round, but September is a special time when the spotlight shines a little brighter.
These efforts include blood drives, community walks, health fairs, and forums where patients can share their stories. These events bring people together. They show that the sickle cell community is not alone. They also remind the public that this disease still affects thousands of families every single day.
If you live in the area, find out what events are happening through SCPASCC. Whether it is a walk-a-thon, a church meeting, or a family fun day, your presence matters. By showing up, you show that you care. Even small acts of support can lift someone’s spirit and make them feel seen.
How You Can Support Real Change

Treatment is only part of the solution. The sickle cell community also needs strong support from the outside. This includes friends, churches, local leaders, and donors who are willing to stand up and take action.
You can help by donating to organizations like SCPASCC that are working directly with patients. These donations often go toward transportation, education, outreach, and patient advocacy. Your money helps real people who need help getting to appointments or understanding their treatment options.
You can also support by volunteering. Whether it is setting up chairs at an event or helping with phone calls, your time makes a difference. If you are active in a church or civic group, ask about hosting a sickle cell awareness event. Sharing space and spreading knowledge is a form of service that brings lasting value.
Do not underestimate the power of checking in. If you know someone living with sickle cell, ask how they are doing. Listen without trying to fix everything. Sometimes just knowing someone cares is enough to help carry the weight of the day.
This September, we do more than raise awareness. We lift up a community that has carried a heavy burden for far too long. With new treatments, better research, and stronger support, there is hope on the horizon. But hope grows stronger when we walk together.
Sources:
FDA on Sickle Cell Treatment Options: https://www.fda.gov/news-events/press-announcements CDC Sickle Cell Overview: https://www.cdc.gov/ncbddd/sicklecell/index.htmlSickle Cell Disease Association of America: https://www.sicklecelldisease.org Clinical Trials for Sickle Cell: https://www.clinicaltrials.gov
NIH on Gene Therapy: https://www.nih.gov/news-events/nih-research-matters/gene-therapy-sickle-cell-diseaseJohns Hopkins Sickle Cell Center: https://www.hopkinsmedicine.org/medicine/hematology/sickle-cell/




Comments